Scinai Immunotherapeutics Ltd. (SCNI)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Oct 09, 16:00
1.195
+0.02
(+1.27%)
After-Hours: 20:00
Scinai Immunotherapeutics Profit Margin (Quarterly) : -435.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -435.4% |
| March 31, 2026 | |
| December 31, 2025 | -787.5% |
| September 30, 2025 | -764.5% |
| June 30, 2025 | -1.38K% |
| Date | Value |
|---|---|
| March 31, 2025 | -265.7% |
| December 31, 2024 | -1.08K% |
| September 30, 2024 | |
| June 30, 2024 | -817.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -269.3% |
| Pluri, Inc. | -1.85K% |
| Evogene Ltd. | -458.5% |
| CollPlant Biotechnologies Ltd. | -2.52K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.03% |
| Return on Assets | -18.31% |
| Return on Invested Capital | -20.85% |
| Gross Profit Margin (Quarterly) | -272.2% |
| Operating Margin (Quarterly) | -466.5% |
| Return on Net Operating Assets | -22.18% |